In this study, we initially show that combination of SDT and celecoxib to down-regulate MDR1 augmented the anti-tumor effects in GSCs and the mouse GSC-bearing malignant glioma model indicating invasive and therapeutic resistance. The gene discussed is ABCB1; the disease is malignant glioma.